IP Library Granted Patent US 7,279,501
Granted Patent B2
US 7,279,501 · App. 11/128,638 · Granted Oct 9, 2007

Pharmaceutical composition useful in prevention and treatment of beta-amyloid protein-induced disease

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,279,501
App. No.
11/128,638
Granted
Oct 9, 2007
Kind
B2
Abstract

The invention provides methods for treating beta-Amyloid protein-induced disease, pharmaceutical compositions and compounds useful for the same, and the use of these compounds for the manufacture of a medicament for treating the same. More particularly, the invention relates to the use of natural product compounds isolated from turmeric, gingko biloba , and ginger, and synthetic chemical analogues thereof, for the treatment of a beta-Amyloid protein-induced disease.

Claims (11)

1. A method for the treatment of a beta-Amyloid protein-induced cytotoxicity comprising administering to a subject suffering from the beta-Amyloid protein-induced cytotoxicity a therapeutically effective amount of a compound having the formula (IV):

or a pharmaceutically acceptable salt or ester thereof, wherein:

R is selected from the group consisting of higher alkyl, higher alkenyl, and higher alkynyl.

2. The method according to claim 1 wherein:

R is

n is 1-7.

3. The method according to claim 1 wherein:

R is selected from the group consisting of

4. The method according to claim 1 wherein the beta-Amyloid induced disease is Alzheimer's Disease.

5. The method according to claim 1 in which the beta-amyloid protein-induced cytotoxicity is neurotoxicity.

6. The method according to claim 1 wherein a purified and isolated compound selected from the group consisting of formula (IV) is administered.

Assignments (1)
RELEASE OF SECURITY INTEREST FILED JANUARY 21, 2026 Recorded Mar 9, 2026
From: ALTER DOMUS (US) LLC
To: RSA SECURITY LLC; RSA SECURITY USA LLC
Reel/Frame 075089/0201 →
Priority Claims (1)
EP 00986827 · Oct 23, 2000 · regional
Continuity (4)
Continuation 1108431600 · Mar 18, 2005
Continuation 1011103900
Provisional Application 6016114500 · Oct 22, 1999
Related Publication 20050239882A1 · Oct 27, 2005